Iboctadekin Uses, Dosage, Side Effects and more
Iboctadekin is under investigation in clinical trial NCT00500058 (A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18).
| Attribute | Details |
|---|---|
| Trade Name | Iboctadekin |
| Generic | Iboctadekin |
| Iboctadekin Other Names | Iboctadekin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
